TVGN Tevogen Bio: Accounting Capitalization
The market price of Tevogen Bio Holdings (TVGN), as confirmed by the chart, serves as an indicator for a business seeking to expand the influence of its T-cell technologies in the therapy of viral and neuropathologies, despite early-stage development risks. The current figure is -0.02. Operations rely on US research centers and capital inflows to conduct clinical trials of immunotherapeutic agents.
%20-%20Company%20Book%20Value&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_TVGN_-_Tevogen-Bio-Holdings_-_Company-Book-Value "TVGN Tevogen Bio Holdings Inc. Accounting Capitalization (02/21/2024 - 10/30/2026) | 👁️GURU.Markets👁️")
TVGN (Tevogen Bio): analytical breakdowns and indicator data
- stock value and consensus price forecast:
- company stock capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Tevogen Bio Holdings|TVGN - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Tevogen Bio Holdings Inc.|TVGN - Company Debts|Debts to Book Value Tevogen Bio Holdings Inc.|TVGN - Company Long-Term Liabilities|Amount of Current Liabilities Tevogen Bio|Immediate Liquidity tevogen.com
- earnings and valuation multiples information:
Initial company analysis:TVGN, Tevogen Bio Inc.
Book value capitalization represents the net asset value minus all liabilities. Growth in this metric confirms the issuer's fundamental stability, separating intrinsic value from speculative price volatility. By analyzing the company's book capital history, an investor assesses the inertia of equity. For Tevogen Bio Holdings (TVGN), this metric reflects the efficiency of raising funds for clinical trials. This confirms the financial foundation for the development of a unique immunotherapy platform.
Direct competitors
Book Value of Business Biogen Idec (BIIB)|Neurocrine Biosciences (NBIX) - Company Book Value|Accounting Capitalization RGC|Company Book Value Axsome Therapeutics, Inc.|Accounting Capitalization ACAD (ACADIA Pharma)|Book Capitalization XENE|VKTX - Total Stockholders' Equity|Supernus Pharmaceuticals - Company Net Assets|Book Capitalization catalystpharma.com CPRX|DNLI - Company Book Value|Accounting Value of Company HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Company Book Value|Total Stockholders' Equity Amylyx Corp (AMLX)|Company Net Assets TRVI|PRAX (praxismedicines.com) - Total Net Assets|Book Capitalization AVXL|CBLL - Total Stockholders' Equity|prothena.com - Company Net Assets|Alector Inc. - Company Book Value|ANNX - Company Book Value|Total Stockholders' Equity Omeros Corporation|NGNE: Book Capitalization|Book Value of Business AC Immune S.A. ACIU|VYGR (Voyager Pharma) - Book Capitalization|Total Stockholders' Equity Neumora Corp NMRA|Company Book Value Scilex Holding Company (SCLX)|alphacognition.com - Accounting Capitalization|Cognition Therapeutics - Company Net Assets|Accounting Value of Company IKT|Cassava - Book Capitalization|ASRT: Company Book Value|COYA: Book Capitalization|VTGN - Book Valuation of Business|Company Book Value Ovid Therapeutics Inc|Total Stockholders' Equity Acumen Pharmaceuticals Inc. ABOS|Company Net Assets CRVO (CervoMed Inc)|ATHE (alteritytherapeutics.com) - Accounting Value of Company|Book Capitalization CLNN (Clene)|Accounting Value of Company PEPG|JUNS - Company Book Value|Total Stockholders' Equity Relmada Therapeutics Inc|Annovis Bio Corp (ANVS) - Company Book Value|GRCE (Grace Therapeutics) - Company Book Value|AIFF (Firefly Neuroscience, Inc) - Book Capitalization|Accounting Capitalization KLTO (ANEW Medical, Inc.)|Book Capitalization NRSN|Book Valuation of Business Reviva Pharmaceuticals Holdings Inc.|Company Book Value MetaVia MTVA|NRXS: Accounting Capitalization|Helius Medical Technologies Inc. - Book Capitalization|Book Value of Business Passage Bio, Inc. (PASG)|bionomics.com.au (NEUP) - Company Book Value|NERV - Book Valuation of Business|Company Net Assets ATHA|ADXN (Addex) - Total Net Assets|Company Net Assets ALZN (Alzamend Neuro, Inc.)|Company Book Value CYCN (cyclerion.com)|Book Capitalization PTIX (Protagenic Therapeutics, Inc.)|Book Value of Business Pasithea Therapeutics Corp|CRGT - Company Book Value|ATXI (Avenue Therapeutics Inc) - Accounting Capitalization|Brainstorm Cell (BCLI) - Company Book Value|Accounting Capitalization CARA|CHRO (Chromocell Therapeutics Corp.) - Book Capitalization|Total Stockholders' Equity Eliem ELYM|Company Net Assets ITCI (Intra-Cellular Therapies)|Book Capitalization Longboard (LBPH)|Company Book Value Marinus Pharmaceuticals MRNS|Accounting Value of Company NKGN|NRBO - Company Book Value|Total Stockholders' Equity Sage Therapeutics Inc.|SNPX (Neurotrope) - Company Net Assets|TRVN: Total Net Assets|VIGL (Vigil Neuroscience Inc.) - Book Capitalization|Total Stockholders' Equity Anew Medical Inc. WENA|Company Net Assets CERE (Cerevel Therapeutics, Inc.)